Our Mission: Improving and Extending the Lives of Patients with Cancer
 
 
 

News & Events

2011 News
 

12/12/11
Celator® Pharmaceuticals and The Leukemia & Lymphoma Society® Announce Positive Data From Phase 2b Study of CPX-351 at the American Society of Hematology Annual Meeting

9/21/11
Celator® Pharmaceuticals Granted U.S. Patent Covering Lead Cancer Product

6/06/11
Celator® Pharmaceuticals Presents Positive Data From Phase 2 Study of CPX-351 at the American Society of Clinical Oncology Meeting

1/10/11
Celator® Pharmaceuticals and Cephalon, Inc. Agree to Extend Research Agreement into Next Phase of Development

 

 

 

News Links:
2012
2011
2010
2009
2008
2007
2006
2005
Upcoming Events

 

 

 



 
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.